Headlines

Life Science Tools Maker Revvity Delivers Strong Q1 Earnings Despite Evolving Macroeconomic Backdrop

Revvity posts strong Q1 results with Life Sciences and Diagnostics growth, lifts 2025 sales guidance, and expects higher adjusted operating margins.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *